Markulan, L. Y., and L. M. Makarevych. “Pembrolizumab As an Immunotherapy Drug in the Treatment of a patient with recurrent (unresectable) Cancer of the Lower Lip”. General Surgery, no. 2 (December 30, 2022): 75–82. Accessed November 22, 2024. http://generalsurgery.com.ua/article/view/270978.